Skip to main navigationSkip to main content
The University of Southampton
Southampton Health Technology Assessments Centre

Growth conditions

Click on the title for more information (where available).

Takeda A, Cooper K, Bird A, Baxter L, Gospodarevskaya E, Frampton G et al. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation. Health Technology Assessment 2010;14(42).

Bryant J, Baxter L, Cave C, Milne R. Recombinant human growth hormone in children and adolescents with idiopathic short stature (Cochrane Review). The Cochrane Database of Systematic Reviews 2007;Issue 3. 

Baxter L, Bryant J, Cave C, Milne R. Recombinant human growth hormone in children and adolescents with Turner Syndrome (Cochrane review).  The Cochrane Database of Systematic reviews 2007;Issue 1.                    

Bryant J, Cave C, Mihaylova B, Chase D, McIntyre L, Gerard K et al. Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation. Health Technology Assessment 2002;6(18).  

Bryant J, Loveman E, Chase D, Mihaylova B, Cave C, Gerard K et al. The clinical effectiveness and cost effectiveness of the use of human growth hormones in adults. Health Technology Assessment 2002;6(19).  

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×